François Zimmermann, François Robin, Leila Caillault, Claire Cazalets, Francisco Llamas-Gutierrez, Ronan Garlantézec, Sandrine Jousse-Joulin, Elisabeth Diot, Sami Eric Mensi, Nicolas Belhomme, Patrick Jégo, Guillaume Coiffier, Alain Lescoat
Journal: Rheumatology (Oxford, England) 2023;62(SI):SI1-SI11
PMID: 35866609
SSc is an auto-immune disease characterized by life-threatening manifestations such as lung fibrosis or pulmonary arterial hypertension. Symptoms with a detrimental impact on quality of life are also reported and sicca syndrome (xerostomia, xeropthalmia) is present in up to 80% of patients with SSc. Sicca syndrome can occur in the absence of overlap with Sjögren's disease and recent studies highlight that fibrosis of minor and major salivary glands, directly linked to the pathogenesis of SSc, could be a major contributor of xerostomia in SSc. This narrative review provides an overview of the clinical presentation, diagnostic strategies, management and future perspectives on sicca syndrome in patients with SSc.
© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: [email protected].
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.